Drug prices don't budge even after pressure from Congress

Drug prices don't budge even after pressure from Congress


In this Wednesday, Sept. 21, 2016 file photo, Mylan CEO Heather Bresch, right, and Dr. Doug Throckmorton, deputy director, Center for Drug Evaluation and Research, Food and Drug Administration , are sworn in on Capitol Hill in Washington, prior to testifying before the House Oversight Committee hearing on EpiPen price increases.



from Biotech News